• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在终末期肝病模型(MELD)时代,成人肝移植后的生存率与移植中心的病例数量无关。

Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era.

作者信息

Northup P G, Pruett T L, Stukenborg G J, Berg C L

机构信息

Division of Gastroenterology and Hepatology, University of Virginia Health System, Virginia, USA.

出版信息

Am J Transplant. 2006 Oct;6(10):2455-62. doi: 10.1111/j.1600-6143.2006.01501.x. Epub 2006 Aug 21.

DOI:10.1111/j.1600-6143.2006.01501.x
PMID:16925567
Abstract

It has been demonstrated that low-volume orthotopic liver transplant centers have poorer outcomes compared to high-volume centers. In light of the recent significant changes in liver transplantation, we performed an analysis of transplant center procedure volume and mortality with data from the Model for End-stage Liver Disease (MELD) era. We analyzed 9909 adult liver transplants performed in the United States since the beginning of the MELD allocation system. Transplant centers were categorized by volume of transplants performed per year. Multivariate survival models were constructed with raw survival as the primary endpoint for both high- and low-volume centers. Thirty percent of centers were categorized as low volume (< or =20 liver transplants per year) and 8.2% of all transplants were performed at low-volume centers. The unadjusted raw mortality rate at 1-year post-transplant at high-volume centers (9.5%, 95% CI 9.4-9.5) was significantly lower than the rate at low-volume centers (10.9%, 95% CI 10.4-11.4), p < 0.001. However, after adjusting for disease severity and multiple donor and recipient factors, transplant center volume was no longer a significant predictor of post-transplant survival (HR 0.99, 95% CI 0.99-1.00, p = 0.22). We conclude that transplant center case volume is no longer a significant predictor of post-transplant survival in the MELD era and factors which are currently unaccounted for in present survival models should be investigated.

摘要

已证明,与高容量中心相比,低容量原位肝移植中心的治疗效果较差。鉴于近期肝移植领域发生的重大变化,我们利用终末期肝病模型(MELD)时代的数据,对移植中心的手术量和死亡率进行了分析。我们分析了自MELD分配系统启用以来在美国进行的9909例成人肝移植手术。移植中心按每年进行的移植手术量进行分类。以原始生存率作为高容量和低容量中心的主要终点,构建多变量生存模型。30%的中心被归类为低容量中心(每年≤20例肝移植),所有移植手术中有8.2%在低容量中心进行。高容量中心移植后1年的未调整原始死亡率(9.5%,95%可信区间9.4 - 9.5)显著低于低容量中心(10.9%,95%可信区间10.4 - 11.4),p<0.001。然而,在对疾病严重程度以及多个供体和受体因素进行调整后,移植中心的手术量不再是移植后生存的显著预测因素(风险比0.99,95%可信区间0.99 - 1.00,p = 0.22)。我们得出结论,在MELD时代,移植中心的病例数量不再是移植后生存的显著预测因素,应研究当前生存模型中未考虑的因素。

相似文献

1
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era.在终末期肝病模型(MELD)时代,成人肝移植后的生存率与移植中心的病例数量无关。
Am J Transplant. 2006 Oct;6(10):2455-62. doi: 10.1111/j.1600-6143.2006.01501.x. Epub 2006 Aug 21.
2
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.肝移植可及性的差异:疾病严重程度、等待时间和移植中心工作量
Ann Intern Med. 2007 May 15;146(10):707-13. doi: 10.7326/0003-4819-146-10-200705150-00004.
3
Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.终末期肝病模型(MELD)评分30分分配政策对意大利肝移植结局的影响。
J Hepatol. 2022 Mar;76(3):619-627. doi: 10.1016/j.jhep.2021.10.024. Epub 2021 Nov 10.
4
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.终末期肝病分配政策模型对高风险肝脏移植器官使用的影响。
Gastroenterology. 2008 Nov;135(5):1568-74. doi: 10.1053/j.gastro.2008.08.003.
5
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.在终末期肝病模型分配时代,活体捐赠对肝移植受者生存获益的影响。
Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.
6
Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.通过供体和受体特征的策略性匹配优化再次肝移植移植物的效用。
Liver Transpl. 2015 Nov;21(11):1365-73. doi: 10.1002/lt.24138.
7
Same policy, different impact: Center-level effects of share 35 liver allocation.相同政策,不同影响:肝脏分配份额35%的中心层面效应
Liver Transpl. 2017 Jun;23(6):741-750. doi: 10.1002/lt.24769.
8
Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?终末期肝病模型(MELD)评分是否不仅足以预测等待名单上的死亡,还能预测移植后的生存率?
Transpl Int. 2006 Apr;19(4):275-81. doi: 10.1111/j.1432-2277.2006.00250.x.
9
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.终末期肝病模型评分不能预测活体肝移植受者的患者或移植物存活率。
Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122.
10
Defining long-term outcomes with living donor liver transplantation in North America.界定北美活体供肝移植的长期预后。
Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.

引用本文的文献

1
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma.与多中心队列研究相比,回顾性单中心队列研究在肝细胞癌预后方面的可推广性有限。
J Hepatocell Carcinoma. 2024 Jul 1;11:1235-1249. doi: 10.2147/JHC.S456093. eCollection 2024.
2
Impact of institutional case volume of solid organ transplantation on patient outcomes and implications for healthcare policy in Korea.韩国实体器官移植机构病例数量对患者预后的影响及对医疗政策的启示
Korean J Transplant. 2023 Mar 31;37(1):1-10. doi: 10.4285/kjt.23.0010.
3
Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients.
丙型肝炎病毒血症供体心脏移植给丙型肝炎病毒血清学阴性受者的趋势及三年结局
JTCVS Open. 2022 Nov 3;12:269-279. doi: 10.1016/j.xjon.2022.10.007. eCollection 2022 Dec.
4
Living donor liver transplant outcomes during the COVID-19 pandemic: does a decrease in case volume impact the overall outcomes?新冠疫情期间活体肝移植的结果:病例数量的减少会影响总体结果吗?
Korean J Transplant. 2022 Jun 30;36(2):127-135. doi: 10.4285/kjt.22.0017.
5
The volume-outcomes relationship in donation after circulatory death liver transplantation.在循环死亡供肝肝移植中,体积与结果的关系。
Clin Transplant. 2022 Jun;36(6):e14658. doi: 10.1111/ctr.14658. Epub 2022 Apr 25.
6
Volume and outcome relation in German liver transplant centers: what lessons can be learned?德国肝脏移植中心的手术量与治疗结果的关系:能吸取哪些经验教训?
Transplant Res. 2014 Feb 10;3(1):5. doi: 10.1186/2047-1440-3-5.
7
Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service.小容量尸体供肝肝移植与强大的活体供肝肝移植服务并行开展。
World J Surg. 2014 Jun;38(6):1522-8. doi: 10.1007/s00268-013-2437-3.
8
Impact of the center on graft failure after liver transplantation.中心对肝移植后移植物失败的影响。
Liver Transpl. 2013 Sep;19(9):957-64. doi: 10.1002/lt.23685. Epub 2013 Jul 26.
9
Centre volume and resource consumption in liver transplantation.肝移植中的中心容积和资源消耗。
HPB (Oxford). 2012 Aug;14(8):554-9. doi: 10.1111/j.1477-2574.2012.00503.x. Epub 2012 Jun 10.
10
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I).肝移植后免疫调节治疗中第三方多能成体祖细胞的安全性和可行性:一项 I 期研究(MISOT-I)。
J Transl Med. 2011 Jul 28;9:124. doi: 10.1186/1479-5876-9-124.